Enhancement of preheparin serum lipoprotein lipase mass by bezafbirate administration
- 1 November 2000
- journal article
- research article
- Published by Elsevier in Atherosclerosis
- Vol. 153 (1) , 175-179
- https://doi.org/10.1016/s0021-9150(00)00394-4
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Lipoprotein Lipase Mass and Activity in Plasma and Their Increase After Heparin Are Separate Parameters With Different Relations to Plasma LipoproteinsArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- The ‘midband’ lipoprotein is a coronary risk factor in Japanese patients with familial hypercholesterolaemiaScandinavian Journal of Clinical and Laboratory Investigation, 1993
- Lipoprotein LipaseNew England Journal of Medicine, 1989
- Increased frequency of lipoprotein disorders similar to type iii hyperlipoproteinemia in survivors of myocardial infarction in JapanAtherosclerosis, 1984
- Lipolytic Enzymes and Plasma Lipoprotein MetabolismAnnual Review of Biochemistry, 1980
- One-year study of the effect of bezafibrate on serum lipoprotein concentrations in hyperlipoproteinaemiaAtherosclerosis, 1978
- Dose-response study of bezafibrate on serum lipoprotein concentrations in hyperlipoproteinaemiaAtherosclerosis, 1978
- The investigation of “mid-band” lipoproteins using polyacrylamide gel electrophoresisClinica Chimica Acta; International Journal of Clinical Chemistry, 1974